Unknown Author
January 24, 2026
Kirkland Advises Blackstone on Majority Investment in Chartis to Advance Mission of Healthcare Transformation

1 min
AI-made summary
- Kirkland & Ellis advised Blackstone-managed funds on a definitive agreement for a majority investment in Chartis, a healthcare advisory firm
- The investment aims to support Chartis’ growth and includes continued equity participation from Audax Private Equity
- The transaction is expected to close by the end of 2024, pending customary closing conditions and regulatory approvals
- Financial terms were not disclosed
- The Kirkland team included partners and associates from corporate, tax, executive compensation, and healthcare regulatory practices.
Kirkland & Ellis advised funds managed by Blackstone on a definitive agreement for a majority investment in Chartis, a leading healthcare advisory firm. This strategic investment will support Chartis’ continued growth as a leading advisor to providers, payers, technology innovators, retail companies and investors who are making positive and transformative change within U.S. healthcare. The investment includes continued equity participation from Audax Private Equity. The transaction is expected to close by the end of 2024, subject to customary closing conditions and regulatory approvals. Terms of the transaction were not disclosed. Read the transaction press release The Kirkland team was led by corporate partners Chris Burwell and Peter Martelli; tax partners Mike Beinus and Vivek Ratnam; executive compensation partners Mike Krasnovsky and Matt Wood; corporate associate James Crisp; and healthcare & life sciences regulatory partners Dennis Williams and Lindsay Borgeson.
Article Author
Unknown Author
The Sponsor
